entertainment -WSS

entertainment

author：Wikipedia 2025-10-01 21:10:03 - browse：6

A caretaker speaks with an elderly Alzheimer's patient at a nursing home. — ALAIN JOCARD/AFP via Getty Images

For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic risk factor for most cases of the devastating neurologic disease. But a new study published on Monday argues that this gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s.

Researchers analyzed data from more than 13,000 people, including nearly 800 APOE4 homozygotes, people who carry two copies of the gene variant. They found that nearly all of the homozygotes showed biological signs of Alzheimer’s in the brain, and they typically developed dementia and other symptoms, and died sooner, than people with Alzheimer’s who lack APOE4.

The research team also found that APOE4 homozygotes showed a predictable pattern of biomarker changes linked to Alzheimer’s, including a buildup of beta-amyloid and tau, a protein linked to neuron damage and death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： STAT Virtual Event: JPM Recap, Live!

WSS

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Nonprofit, backed by Microsoft, to certify AI tools in health care

New safety details link Apellis eye drug to rare cases of blindness

EQRx, failed developer of low

A preacher's new calling: Diversifying neuroscience research

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

Study suggests new cause of Down syndrome: cells linked to aging

The high cost of giving birth even with insurance

Study suggests new cause of Down syndrome: cells linked to aging

Wildfire smoke exposes gaps in outdoor worker protections

Profiling embryos to choose those with higher IQs is almost a reality

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Amazon expands telehealth clinic nationwide

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Breakthrough Alzheimer’s drugs are inaccessible in rural states

explore

STAT Virtual Event: JPM Recap, Live!

The high personal cost of affirmative action for Black doctors

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Nonprofit, backed by Microsoft, to certify AI tools in health care

What to expect as Trump is arraigned on his Jan 6. indictment

Ascension's ugly legal battle over care for poor patients in Texas

focus

knowledge

explore

focus